Peter B. Coggins

Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston.

IMCOR Pharmaceutical Co. is a development-stage pharmaceutical company focused on developing medical imaging pharmaceutical products. Currently, the company's core business focus has evolved from an operating entity conducting research and development, manufacturing and limited selling activities. The company was founded by H. Craig Dees and Eric A. Wachter on December 28, 1994 and is headquartered in San Diego, CA.

Redpath Partners, Inc. provides complex cancer diagnostic testing for pathologists, oncologists and clinicians. The company was founded by Del Mary Brady and Sydney D. Finkelstein and is headquartered in Pittsburgh, PA.

SVB Leerink Holdings LLC operates as an investment bank holding company with interest in investment services. The firm provides equity research, institutional sales and trading, corporate finance and strategic advisory services. The company was founded in 1995 and is headquartered in Boston, MA.

Avaxia Biologics, Inc. operated as a clinical-stage biotechnology company. It engaged in the development of gut-targeted antibody therapeutics for gastroenterology indications. Gut-targeted antibody therapeutics is orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal (GI) tract including the mouth, throat, and intestines. The company was founded by David Poorvin and Barbara S. Fox in 2005 and was headquartered in Lexington, MA.

Continuus Pharmaceuticals, Inc. engages in the development continuous manufacturing platform. It offers ICM (Integrated Continuous Manufacturing), which enables non-stop processes that incorporate API formation steps with final drug product formulation. The company was founded was founded by Salvatore Mascia and Bayan Takizawa in 2012 and is headquartered in Woburn, MA.

Chrysalis Ventures, Inc (Chrysalis Ventures) is a private equity firm founded by David Jones, Jr in 1993. The firm is headquartered in the Louisville, KY.

Medica Venture Partners (Medica Venture Partners) is a venture capital firm founded in 1995 by Yuval Binur, Ehud Geller and Jonathan Fleming. The firm is headquartered in Israel.

Apjohn Ventures LLC (Apjohn Ventures) is a venture capital subsidiary of Apjohn Group LLC founded in 2002 by Mina Patel Sooch and Donald R Parfet. The firm is headquartered in Kalamazoo, Michigan.

Cullinane & Donnelly Venture Partners (Cullinane & Donnelly Venture Partners) is a venture capital firm founded in 1987. The firm is headquartered in Southport, Connecticut.

Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA.

New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA.

Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.

20/20 HealthCare Partners LLC (20/20 HealthCare Partners) is a venture capital firm founded in 2005 by Hillel Bachrach. The firm is headquartered in Auburndale, Massachusetts.

GreenLight Biosciences, Inc. engages in a biotechnology company.. It delivers attractive solution for production of chemicals and fuels from renewable resources, eliminating the need for petroleum feedstocks. The company was founded by Andrey J. Zarur, Marta Ortega-Valle, and James R. Swartz and is headquartered in Medford, MA.

Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura.

RailRunner N.A., Inc. develops Road-Ready bi-modal rail system, a railcar, trailer, and container chassis system that is enabling container-based intermodal transportation service to a market of manufacturers, farmers, shippers, wholesalers, and retailers who are not located near traditional intermodal hubs. The company is headquartered in Waltham, MA.

Jubilant DraxImage, Inc. engages in the provision of development, manufacturing, and commercialization of radiopharmaceuticals. Its product Drax Exametazime used for the diagnosis and treatment of disease such as intra-abdominal infection and inflammatory bowel disease. The company is headquartered in Kirkland, Canada.

EightSpokes, Inc. develops a SaaS platform for execution of management life cycle initiatives such as product development, global product launches, and lifecycle management of in-market products. Its software solution Enlighten, a management software that replace the majority of the manual planning, coordination and communication problems that occur. The company was founded in 2012 and is headquartered in Cambridge, MA.

Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA.

QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA.

Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA.

Novatio Ventures (Novatio Ventures) is a venture capital firm founded in 2015 by Peng Fu. The firm is headquartered in Toronto, Canada.

Onc.ai, Inc. is a digital health company that is privately held and is developing a precision oncology care management platform. The company is based in San Carlos, CA. The company aims to transform clinical decision making and is backed by premier investment firms such as the Blue Venture Fund, MassMutual Alternative Investments, and Accomplice, among others. The company is building a pipeline of physician-centered products to fulfill the potential of precision oncology. The company was founded by Akshay Nanduri, who has been the CEO since incorporation.